When Drugs and Devices Come Together, Safety Considerations Get More Complex Dr. Khaudeja Bano, Vice President Combination Product Quality at Amgen, joined the Safety Signals
More than Just Paper Shuffling and Regulations Yvonne Nanciu joined the Safety Signals Podcast to explain how pharmacovigilance can be a rich and rewarding field.
Small Patient Populations Pose Unique Challenges for Safety Scientists Peter Hawkins, Senior Director, Head of Rare Genetic Disease Risk Management at Agios Pharmaceuticals, joined the
Emerging Professionals Must Understand Data Science and AI “The number one priority that I have at the moment is thinking about the PV professional of
As Data Explodes, Safety Scientists Need to Be More Tech Savvy Young people interested in a career in pharmacovigilance are learning about computer science and
What Does Drug Safety Mean from the Patient’s Perspective? Rakesh Raman, M.D., Senior Director, Head of Medical Safety at REVOLUTION Medicines, joined the Safety Signals
By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.
Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.
By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.
Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.